(Q47817428)
Statements
A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol (English)
Magnus Björkholm
Bengt Fagrell
Robert Przybelski
Nancy Winslow
Mark Young
Robert M Winslow